These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 33390847

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS, Tseng HY, Chen YA, Shen PC, Al Haq AT, Chen LM, Tung YC, Hsu HL.
    Mol Cancer; 2019 Mar 18; 18(1):42. PubMed ID: 30885232
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells.
    Xu Z, Liu C, Zhao Q, Lü J, Ding X, Luo A, He J, Wang G, Li Y, Cai Z, Wang Z, Liu J, Liu S, Li W, Yu Z.
    Pharmacol Res; 2020 Feb 18; 152():104628. PubMed ID: 31904506
    [Abstract] [Full Text] [Related]

  • 8. MiR-7 reduces the BCSC subset by inhibiting XIST to modulate the miR-92b/Slug/ESA axis and inhibit tumor growth.
    Li M, Pan M, You C, Zhao F, Wu D, Guo M, Xu H, Shi F, Zheng D, Dou J.
    Breast Cancer Res; 2020 Mar 06; 22(1):26. PubMed ID: 32143670
    [Abstract] [Full Text] [Related]

  • 9. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
    Chen JH, Kuo KT, Bamodu OA, Lin YC, Yang RB, Yeh CT, Chao TY.
    Exp Cell Res; 2018 Sep 15; 370(2):444-453. PubMed ID: 29981340
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer.
    Ji S, Yu H, Zhou D, Fan X, Duan Y, Tan Y, Lang M, Shao G.
    J Transl Med; 2023 Oct 14; 21(1):721. PubMed ID: 37838657
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells.
    Moon JH, Lee SH, Koo BS, Kim JM, Huang S, Cho JH, Eun YG, Shin HA, Lim YC.
    Oral Oncol; 2020 Dec 14; 111():104948. PubMed ID: 32771963
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer.
    Tian J, Hachim MY, Hachim IY, Dai M, Lo C, Raffa FA, Ali S, Lebrun JJ.
    Sci Rep; 2017 Jan 05; 7():40258. PubMed ID: 28054666
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
    Granados-Principal S, Liu Y, Guevara ML, Blanco E, Choi DS, Qian W, Patel T, Rodriguez AA, Cusimano J, Weiss HL, Zhao H, Landis MD, Dave B, Gross SS, Chang JC.
    Breast Cancer Res; 2015 Feb 22; 17(1):25. PubMed ID: 25849745
    [Abstract] [Full Text] [Related]

  • 20. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L, Nuncia-Cantarero M, Morcillo-Garcia S, Nieto-Jimenez C, Burgos M, Corrales-Sanchez V, Perez-Peña J, Győrffy B, Ocaña A, Galán-Moya EM.
    Cell Oncol (Dordr); 2020 Jun 22; 43(3):431-444. PubMed ID: 32166583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.